1. Home
  2. HCM vs SXI Comparison

HCM vs SXI Comparison

Compare HCM & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • SXI
  • Stock Information
  • Founded
  • HCM 2000
  • SXI 1955
  • Country
  • HCM Hong Kong
  • SXI United States
  • Employees
  • HCM N/A
  • SXI N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • SXI Industrial Machinery/Components
  • Sector
  • HCM Health Care
  • SXI Industrials
  • Exchange
  • HCM Nasdaq
  • SXI Nasdaq
  • Market Cap
  • HCM 2.5B
  • SXI 2.3B
  • IPO Year
  • HCM N/A
  • SXI N/A
  • Fundamental
  • Price
  • HCM $13.76
  • SXI $136.23
  • Analyst Decision
  • HCM Hold
  • SXI Strong Buy
  • Analyst Count
  • HCM 1
  • SXI 3
  • Target Price
  • HCM $19.00
  • SXI $231.33
  • AVG Volume (30 Days)
  • HCM 128.4K
  • SXI 90.6K
  • Earning Date
  • HCM 03-19-2025
  • SXI 05-01-2025
  • Dividend Yield
  • HCM N/A
  • SXI 0.94%
  • EPS Growth
  • HCM N/A
  • SXI N/A
  • EPS
  • HCM 0.04
  • SXI 4.56
  • Revenue
  • HCM $630,201,000.00
  • SXI $717,739,000.00
  • Revenue This Year
  • HCM $28.98
  • SXI $10.03
  • Revenue Next Year
  • HCM $20.41
  • SXI $13.78
  • P/E Ratio
  • HCM $63.68
  • SXI $29.76
  • Revenue Growth
  • HCM N/A
  • SXI N/A
  • 52 Week Low
  • HCM $11.51
  • SXI $130.05
  • 52 Week High
  • HCM $21.92
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • HCM 46.20
  • SXI 32.45
  • Support Level
  • HCM $13.50
  • SXI $134.09
  • Resistance Level
  • HCM $15.11
  • SXI $145.06
  • Average True Range (ATR)
  • HCM 0.66
  • SXI 7.57
  • MACD
  • HCM -0.00
  • SXI -0.48
  • Stochastic Oscillator
  • HCM 45.69
  • SXI 18.63

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

Share on Social Networks: